company background image
STAA logo

STAAR Surgical NasdaqGM:STAA Rapporto sulle azioni

Ultimo prezzo

US$26.38

Cap. di mercato

US$1.3b

7D

-7.2%

1Y

-21.7%

Aggiornato

20 Nov, 2024

Dati

Dati finanziari dell'azienda +

STAAR Surgical Company

NasdaqGM:STAA Rapporto sulle azioni

Cap. di mercato: US$1.3b

STAA Panoramica delle azioni

STAAR Surgical Company, insieme alle sue consociate, progetta, sviluppa, produce, commercializza e vende lenti impiantabili per l'occhio e i relativi sistemi di applicazione delle lenti nell'occhio. Maggiori dettagli

STAA analisi fondamentale
Punteggio fiocco di neve
Valutazione2/6
Crescita futura4/6
Prestazioni passate2/6
Salute finanziaria6/6
Dividendi0/6

Premi

Analisi del rischio

Non sono stati rilevati rischi per STAA dai nostri controlli di rischio.

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

STAAR Surgical Company Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per STAAR Surgical
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$26.38
Massimo di 52 settimaneUS$52.68
Minimo di 52 settimaneUS$26.06
Beta0.62
1Variazione di 1 mese-14.04%
Variazione a 3 mesi-22.34%
Variazione di 1 anno-21.74%
3Variazione a 3 anni-74.54%
Variazione a 5 anni-28.49%
Variazione dall'IPO11.07%

Notizie e aggiornamenti recenti

Recent updates

Return Trends At STAAR Surgical (NASDAQ:STAA) Aren't Appealing

Oct 24
Return Trends At STAAR Surgical (NASDAQ:STAA) Aren't Appealing

STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize

Sep 05

Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 10
Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear

Aug 05
STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear

The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing

Jul 12
The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

May 27
Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

Apr 26
Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge

Apr 05

STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

Mar 25
STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade

Mar 13

STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Mar 07
STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Jan 31
Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Jan 05
With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Nov 30
Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Nov 12
Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Oct 25
Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Aug 24
Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Jul 02
Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Jun 17
Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

May 13
Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Mar 26
A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Mar 12
STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Feb 13
Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Jan 28
Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Dec 15
Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

Dec 01
The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?

Oct 26
What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?

Keep Adding To STAAR Surgical Longs, Buy Thesis Remains

Sep 20

Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

Sep 05
Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate

Aug 21
STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate

STAAR Surgical rises 15% on Q2 result beat

Aug 11

Rendimenti per gli azionisti

STAAUS Medical EquipmentUS Mercato
7D-7.2%-0.8%-1.2%
1Y-21.7%20.9%30.4%

Ritorno vs Industria: STAA ha avuto una performance inferiore rispetto al US Medical Equipment che ha registrato un rendimento 20.9 % nell'ultimo anno.

Rendimento vs Mercato: STAA ha avuto una performance inferiore al mercato US che ha registrato un rendimento 30.4 % nell'ultimo anno.

Volatilità dei prezzi

Is STAA's price volatile compared to industry and market?
STAA volatility
STAA Average Weekly Movement7.4%
Medical Equipment Industry Average Movement7.9%
Market Average Movement6.2%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.1%

Prezzo delle azioni stabile: STAA non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 7% ) di STAA è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
19821,057Tom Frinziwww.staar.com

STAAR Surgical Company, insieme alle sue consociate, progetta, sviluppa, produce, commercializza e vende lenti impiantabili per l'occhio e i relativi sistemi di applicazione per il rilascio delle lenti nell'occhio. L'azienda fornisce una famiglia di lenti impiantabili Collamer (ICL) per il trattamento di disturbi visivi quali miopia, ipermetropia, astigmatismo e presbiopia. L'azienda commercializza i propri prodotti a fornitori di servizi sanitari, tra cui chirurghi oftalmici, centri oculistici e chirurgici, ospedali, strutture governative e distributori, e i prodotti sono utilizzati principalmente da oftalmologi.

STAAR Surgical Company Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di STAAR Surgical con la sua capitalizzazione di mercato?
STAA statistiche fondamentali
Capitalizzazione di mercatoUS$1.29b
Guadagni(TTM)US$21.78m
Ricavi(TTM)US$341.22m

59.7x

Rapporto P/E

3.8x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
STAA Conto economico (TTM)
RicaviUS$341.22m
Costo del fatturatoUS$72.57m
Profitto lordoUS$268.66m
Altre speseUS$246.88m
GuadagniUS$21.78m

Ultimi guadagni dichiarati

Sep 27, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)0.44
Margine lordo78.73%
Margine di profitto netto6.38%
Rapporto debito/patrimonio netto0%

Come si è comportato STAA nel lungo periodo?

Vedi performance storica e confronto